RECENT NEWS
Wall Street Journal  4 hrs ago  Comment 
Swedish specialty pharmaceuticals company Meda has rejected an indicative proposal from U.S. generic drug group Mylan to combine the two businesses.
DailyFinance  4 hrs ago  Comment 
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Ferring Pharmaceuticals today announced their collaboration with the World Health Organization (WHO) to advance a new, proprietary formulation of...
Jutia Group  5 hrs ago  Comment 
[Business Wire] - Merck , known as MSD outside the United States and Canada, and Ferring Pharmaceuticals today announced their collaboration with the World Health Organization to advance a new, proprietary formulation of carbetocin, used to...
New York Times  6 hrs ago  Comment 
The Swedish drug maker Meda said Friday that it rejected a takeover offer from the generic pharmaceutical company Mylan. A merger would have allowed Mylan to get tax benefits from being reincorporated abroad.
DailyFinance  Apr 3  Comment 
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced that results from its two Phase III clinical trials of eluxadoline in patients with diarrhea-predominant irritable bowel syndrome will be presented in a Late-Breaking...
DailyFinance  Apr 3  Comment 
TORONTO, ON -- (Marketwired) -- 04/03/14 -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces the appointment of Mr. Kent A. Deuters to the position of Chief Operations Officer and Special Advisor. Kent Deuters adds 20 years of financial...
FierceBiotech  Apr 3  Comment 
A month removed from raising $45 million in venture backing, San Diego's Lumena Pharmaceuticals wants $75 million more as it plots a Wall Street debut, piling up cash to advance its two liver treatments.
Benzinga  Apr 2  Comment 
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designations for both the intravenous (IV) and oral formulations of the company's lead antibiotic candidate,...
DailyFinance  Apr 1  Comment 
Eagle Pharmaceuticals, Inc. ("Eagle") (NASDAQ:EGRX) announced today that the United States Patent and Trademark Office has granted Patent No. 8,685,460 for the treatment of heat stroke with Eagle’s dantrolene sodium for...
New York Times  Mar 31  Comment 
Elan Pharmaceuticals is seeking to recoup the more than $1.5 million in legal fees it paid to comply with document requests by the federal government.




 

This is a list of sub-industries in the pharmaceuticals industry, and a list of their member companies



Drug Delivery

Drug Manufacturers - Major

Drug Manufacturers - Other

Drug Related Products

Biotechnology

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki